2Lee S Y, Kang H R, Song W J, et al. Overcoming oxaliplatin hypersensitivity-different strategies are needed according to the severity and previous exposure[J].Cancer Chemother Pharmacol, 2014, 73 (5) :1021-1029.
6Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J]. N Engl J Med, 2004, 350(23): 2343-2351.
7Santini D, Tonini G, Salerno A, et al. Idiosyncratic reaction after oxaliplatin infusion[J]. Ann Oncol, 2001, 12(1): 132- 133.
8Kitada N, Dan T, Takara K, et al. Oxaliplatin-induced hypersensitivity reaction displaying marked elevation of immunoglobulin E [J]. J Oncol Pharm Pract, 2007, 13(4): 233-235.
9Meyer L, Zuberbier T, Worm M, et al. Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule [J]. J Clin Oncol, 2002, 20 (4): 1146- 1147.
10Cobo F, De Celis G, Pereira A, et al.Oxaliplatin-indueed immune hemolytic anemia: a case report and review of the literature [J]. Anticancer Drugs, 2007, 18 (8):973-976.
